This brand name is authorized in Nigeria.
The drug KETOFUNG contains one active pharmaceutical ingredient (API):
1
|
UNII
R9400W927I - KETOCONAZOLE
|
|
Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-4981 | Cream | Ketofung Cream CREAM 2% | 437 Ketoconazole Cream 04-4981 Ketofung Cream Ketoconazole Powder, Liquid Paraffin, Stearic Acid, Ceto-Stearyl Alcohol, Sodium Meta Bi-Sulphite, Propylene Glycol, Benzyl Alcohol, Fragrance, Purified Water To Lt Dermatological Agents Cutaneous/Topical Route 2.0kg, 4.5kg, 4.5kg, 5.5kg, 0.5kg, 4.5kg, 5.5kg, 4.5kg, 1.0kg, 376kg, 100lt Cream Prescription Only Medicine (Pom) Drugfield Pharmaceuticals Limited Drugfield Pharmaceuticals Limited Nigeria 07/05/2021 06/05/2026 | 07/05/2021 |
| A11-100566 | Shampoo | KETOFUNG SHAMPOO SHAMPOO 2% 100ml | KETOFUNG SHAMPOO KETOCONAZOLE 2% W/W Ketoconazole 48.00g, Guar Hydroxypropyltrimonium Chloride 2.40g, Cocamidopropyl Betaine (Dehyton®PK 45) 129.60g, Sodium Laureth Sulphate (Texapon®N70) 360.00g, Cocamide DEA (Comperlan®COD) 72.00g, Coco-Glucoside (and) Glyceryloleate (Lamesoft®PO 65) 72.00g, Lemon Grass Fragrance 19.20g, Butylated HydroxyAnisole 2.40g, Erythrosine Lake 0.12g, Sodium Chloride 9.60g, Disodium EDTA 12.00g, Purified Water 1,672.68g Drugs Nigerian Products 100ml POM 1 30/09/2022 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D01AC08 | Ketoconazole | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-4981, A11-100566 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.